Medtronic (NYSE:MDT) issued an update on its FY 2020 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of $5.44-5.50 for the period, compared to the Thomson Reuters consensus estimate of $5.44. The company issued revenue guidance of $31.779-31.779 billion, compared to the consensus revenue estimate of $31.7 billion.Medtronic also updated its FY20 guidance to $5.44-5.50 EPS.
NYSE MDT traded up $1.56 during trading on Thursday, reaching $90.32. 232,378 shares of the company’s stock traded hands, compared to its average volume of 4,874,998. The company has a debt-to-equity ratio of 0.47, a quick ratio of 1.92 and a current ratio of 2.36. The company has a market capitalization of $117.71 billion, a price-to-earnings ratio of 18.61, a price-to-earnings-growth ratio of 2.18 and a beta of 0.78. Medtronic has a 12-month low of $81.66 and a 12-month high of $100.15.
Medtronic (NYSE:MDT) last posted its earnings results on Thursday, May 23rd. The medical technology company reported $1.54 EPS for the quarter, beating analysts’ consensus estimates of $1.47 by $0.07. The business had revenue of $8.15 billion for the quarter, compared to the consensus estimate of $8.12 billion. Medtronic had a net margin of 16.10% and a return on equity of 13.85%. The company’s revenue for the quarter was up .0% on a year-over-year basis. During the same quarter last year, the firm posted $1.42 EPS. Equities analysts expect that Medtronic will post 5.15 earnings per share for the current fiscal year.
ILLEGAL ACTIVITY WARNING: This piece of content was first published by Baseball Daily News and is the sole property of of Baseball Daily News. If you are accessing this piece of content on another website, it was illegally copied and reposted in violation of U.S. & international trademark and copyright legislation. The correct version of this piece of content can be accessed at https://www.baseballdailydigest.com/news/2019/05/23/medtronic-mdt-releases-fy-2020-earnings-guidance.html.
Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. It operates through four segments: Cardiac and Vascular Group, Minimally Invasive Therapies Group, Restorative Therapies Group, and Diabetes Group.
See Also: Key terms to understand channel trading
Receive News & Ratings for Medtronic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medtronic and related companies with MarketBeat.com's FREE daily email newsletter.